Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA 2014;311(18):1901–1911. DOI: 10.1001/jama.2014.3192.
Pastor SA, Singh K, Lee DA, et al. Cyclophotocoagulation: a report by the American Academy of Ophthalmology. Ophthalmology 2001;108(11):2130–2138. DOI: 10.1016/s0161-6420(01) 00889-2.
Ramli N, Htoon HM, Ho CL, et al. Risk factors for hypotony after transscleral diode cyclophotocoagulation. J Glaucoma 2012;21(3):169–173. DOI: 10.1097/IJG.0b013e318207091a.
Osman EA, Al-Muammar A, Mousa A, et al. Controlled cyclophotocoagulation with diode laser in refractory glaucoma and long term follow up at King Abdulaziz University Hospital, Riyadh. Saudi J Ophthalmol Off J Saudi Ophthalmol Soc 2010;24(1):9–13. DOI: 10.1016/j.sjopt.2009.12.002.
Ansari E, Gandhewar J. Long-term efficacy and visual acuity following transscleral diode laser photocoagulation in cases of refractory and non-refractory glaucoma. Eye Lond Engl 2007;21(7):936–940. DOI: 10.1038/sj.eye.6702345.
Frezzotti P, Mittica V, Martone G, et al. Longterm follow-up of diode laser transscleral cyclophotocoagulation in the treatment of refractory glaucoma. Acta Ophthalmol (Copenh) 2010;88(1):150–155. DOI: 10.1111/j.1755-3768.2008.01354.x.
Grueb M, Rohrbach JM, Bartz-Schmidt KU, et al. Transscleral diode laser cyclophotocoagulation as primary and secondary surgical treatment in primary open-angle and pseudoexfoliatve glaucoma. Long-term clinical outcomes. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol 2006;244(10):1293–1299. DOI: 10.1007/s00417-006-0280-z.
Lavia C, Dallorto L, Maule M, et al. Minimally-invasive glaucoma surgeries (MIGS) for open angle glaucoma: a systematic review and meta-analysis. PLoS ONE 2017;12(8):e0183142. DOI: 10.1371/journal.pone.0183142.
Zaarour K, Abdelmassih Y, Arej N, et al. Outcomes of micropulse transscleral cyclophotocoagulation in uncontrolled glaucoma patients. J Glaucoma 2019;28(3):270–275. DOI: 10.1097/IJG.0000000000001174.
Aquino MCD, Barton K, Tan AMWT, et al. Micropulse versus continuous wave transscleral diode cyclophotocoagulation in refractory glaucoma: a randomized exploratory study. Clin Experiment Ophthalmol 2015;43(1):40–46. DOI: 10.1111/ceo.12360.
Tan AM, Chockalingam M, Aquino MC, et al. Micropulse transscleral diode laser cyclophotocoagulation in the treatment of refractory glaucoma. Clin Experiment Ophthalmol 2010;38(3):266–272. DOI: 10.1111/j.1442-9071.2010.02238.x.
Sanchez FG, Peirano-Bonomi JC, Brossard Barbosa N, et al. Update on micropulse transscleral cyclophotocoagulation. J Glaucoma 2020;29(7):598–603. DOI: 10.1097/IJG.0000000000001539.
Lee JH, Shi Y, Amoozgar B, et al. Outcome of Micropulse laser transscleral cyclophotocoagulation on pediatric versus adult glaucoma patients. J Glaucoma 2017;26(10):936–939. DOI: 10.1097/IJG.0000000000000757.
Kuchar S, Moster MR, Reamer CB, et al. Treatment outcomes of micropulse transscleral cyclophotocoagulation in advanced glaucoma. Lasers Med Sci 2016;31(2):393–396. DOI: 10.1007/s10103-015-1856-9.
Williams AL, Moster MR, Rahmatnejad K, et al. Clinical efficacy and safety profile of Micropulse transscleral cyclophotocoagulation in refractory glaucoma. J Glaucoma 2018;27(5):445–449. DOI: 10.1097/IJG.0000000000000934.
Dastiridou AI, Katsanos A, Denis P, et al. Cyclodestructive procedures in glaucoma: a review of current and emerging options. Adv Ther 2018;35(12):2103–2127. DOI: 10.1007/s12325-018-0837-3.
Amoozgar B, Phan EN, Lin SC, et al. Update on ciliary body laser procedures. Curr Opin Ophthalmol 2017;28(2):181–186. DOI: 10.1097/ICU.0000000000000351.
Moussa K, Feinstein M, Pekmezci M, et al. Histologic changes following continuous wave and micropulse transscleral cyclophotocoagulation: a randomized comparative study. Transl Vis Sci Technol 2020;9(5):22–22. DOI: 10.1167/tvst.9.5.22.
Schubert HD, Agarwala A. Quantitative CW Nd:YAG pars plana transscleral photocoagulation in postmortem eyes. Ophthalmic Surg 1990;21(12):835–839.
Liu GJ, Mizukawa A, Okisaka S. Mechanism of intraocular pressure decrease after contact transscleral continuous-wave Nd:YAG laser cyclophotocoagulation. Ophthalmic Res 1994;26(2):65–79. DOI: 10.1159/000267395.
Barac R, Vuzitas M, Balta F. Choroidal thickness increase after micropulse transscleral cyclophotocoagulation. Romanian J Ophthalmol 2018;62(2):144–148. DOI: 10.22336/rjo.2018.21.
Sanchez FG, Peirano-Bonomi JC, Grippo TM. Micropulse transscleral cyclophotocoagulation: a hypothesis for the ideal parameters. Med Hypothesis Discov Innov Ophthalmol J 2018;7(3):94–100.
Johnstone MA, Song S, Padilla S, et al. Microscope real-time video (MRTV), high-resolution OCT (HR-OCT) & histopathology (HP) to assess how transcleral micropulse laser (TML) affects the sclera, ciliary body (CB), muscle (CM), secretory epithelium (CBSE), suprachoroidal space (SCS) & aqueous outflow system. Invest Ophthalmol Vis Sci 2019;60(9):2825–2825.
Abdelrahman AM, El Sayed YM. Micropulse versus continuous wave transscleral cyclophotocoagulation in refractory pediatric glaucoma. J Glaucoma 2018;27(10):900–905. DOI: 10.1097/IJG.0000000000001053.
Souissi S, Baudouin C, Labbé A, et al. Micropulse transscleral cyclophotocoagulation using a standard protocol in patients with refractory glaucoma naive of cyclodestruction. Eur J Ophthalmol 2019;31(1):112–119. DOI: 10.1177/1120672119877586.
Garcia GA, Nguyen CV, Yelenskiy A, et al. Micropulse transscleral diode laser cyclophotocoagulation in refractory glaucoma: short-term efficacy, safety, and impact of surgical history on outcomes. Ophthalmol Glaucoma 2019;2(6):402–412. DOI: 10.1016/j.ogla.2019.08.009.
Preda MA, Karancsi OL, Munteanu M, et al. Clinical outcomes of micropulse transscleral cyclophotocoagulation in refractory glaucoma-18 months follow-up. Lasers Med Sci 2020;35(7):1487–1491. DOI: 10.1007/s10103-019-02934-x.
Nguyen AT, Maslin J, Noecker RJ. Early results of micropulse transscleral cyclophotocoagulation for the treatment of glaucoma. Eur J Ophthalmol 2020;30(4):700–705. DOI: 10.1177/112067211 9839303.
Magacho L, Lima FE, Ávila MP. Double-session micropulse transscleral laser (CYCLO G6) as a primary surgical procedure for glaucoma. J Glaucoma 2020;29(3):205–210. DOI: 10.1097/IJG.00000000 00001426.
Magacho L, Lima FE, Ávila MP. Double-session micropulse transscleral laser (CYCLO G6) for the treatment of glaucoma. Lasers Med Sci 2020;35(7):1469–1475. DOI: 10.1007/s10103-019-02922-1.
Varikuti VNV, Shah P, Rai O, et al. Outcomes of micropulse transscleral cyclophotocoagulation in eyes with good central vision. J Glaucoma 2019;28(10):901–905. DOI: 10.1097/IJG.0000000000001339.
Yelenskiy A, Gillette TB, Arosemena A, et al. Patient outcomes following micropulse transscleral cyclophotocoagulation: intermediate-term results. J Glaucoma 2018;27(10):920–925. DOI: 10.1097/IJG.0000000000001023.
Subramaniam K, Price MO, Feng MT, et al. Micropulse transscleral cyclophotocoagulation in keratoplasty eyes. Cornea 2019;38(5):542–545. DOI: 10.1097/ICO.0000000000001897.
Sarrafpour S, Saleh D, Ayoub S, et al. Micropulse transscleral cyclophotocoagulation: a look at long-term effectiveness and outcomes. Ophthalmol Glaucoma 2019;2(3):167–171. DOI: 10.1016/j.ogla.2019.02.002.
Al Habash A, AlAhmadi AS. Outcome of MicroPulse(®) transscleral photocoagulation in different types of glaucoma. Clin Ophthalmol Auckl NZ 2019;13:2353–2360. DOI: 10.2147/OPTH.S226554.
Keilani C, Benhatchi N, Bensmail D, et al. Comparative effectiveness and tolerance of subliminal subthreshold transscleral cyclophotocoagulation with a duty factor of 25% versus 31.3% for advanced glaucoma. J Glaucoma 2020;29(2):97–103. DOI: 10.1097/IJG.0000000000001409.
Vig N, Ameen S, Bloom P, et al. Micropulse transscleral cyclophotocoagulation: initial results using a reduced energy protocol in refractory glaucoma. Graefes Arch Clin Exp Ophthalmol Albrecht Von Graefes Arch Klin Exp Ophthalmol 2020;258(5):1073–1079. DOI: 10.1007/s00417-020-04611-0.
Sahu DK, Namperumalsamy P, Hilton GF, et al. Bullous variant of idiopathic central serous chorioretinopathy. Br J Ophthalmol 2000;84(5):485–492. DOI: 10.1136/bjo.84.5.485.
Sanchez FG, Lerner F, Sampaolesi J, et al. Efficacy and safety of Micropulse® transscleral cyclophotocoagulation in glaucoma. Arch Soc Espanola Oftalmol 2018;93(12):573–579. DOI: 10.1016/j.oftal.2018.08.003.
Dhanireddy S, Yin HY, Dosakayala N, et al. Severe inflammation and hyphema after micropulse diode transscleral cyclophotocoagulation. J Glaucoma 2020;29(6):e50–e52. DOI: 10.1097/IJG.00000000 00001508.
Perez CI, Han Y, Rose-Nussbaumer J, et al. Neurotrophic keratitis after micropulse transscleral diode laser cyclophotocoagulation. Am J Ophthalmol Case Rep 2019;15:100469. DOI: 10.1016/j.ajoc.2019.100469.
Kim J, Sung MS, Park SW. Neurotrophic keratopathy after micropulse transscleral cycloophotocoagulation in a glaucoma patient. Korean J Ophthalmol 2020;35(1):97–98. DOI: 10.3341/kjo.2020. 0103.
Prager AJ, Anchala AR. Suprachoroidal hemorrhage after micropulse cyclophotocoagulation diode therapy. Am J Ophthalmol Case Rep 2020;18:100659. DOI: 10.1016/j.ajoc.2020. 100659.
Kiyama Y, Nakashima K-I, Inoue T. A case of primary open-angle glaucoma with conjunctival laceration after micropulse transscleral cyclophotocoagulation. J Glaucoma 2020;29(12):e135–e137. DOI: 10.1097/IJG.0000000000001658.
Chan PP, Lam MCW, Baig N. Case report - acute corneal subepithelial hydrops (ACSH) during micropulse transscleral cyclophotocoagulation (MPTSC). BMC Ophthalmol 2020;20(1):409. DOI: 10.1186/s12886-020-01669-6.